Literature DB >> 15550394

Site-specific disulfide capture of agonist and antagonist peptides on the C5a receptor.

Elizabeth Buck1, Henry Bourne, James A Wells.   

Abstract

The manner by which peptidic ligands bind and activate their corresponding G-protein-coupled receptors is not well understood. One of the better characterized peptidic ligands is the chemotactic cytokine complement factor 5a (C5a), a 74-amino acid helical bundle. Previous studies showed 6-mer peptide analogs derived from the C terminus of the C5a ligand can bind to C5aR (Kd values approximately 0.1-1 microm) and either agonize or antagonize the receptor (Gerber, B. O., Meng, E. C., Dotsch, V., Baranski, T. J., and Bourne, H. R. (2001) J. Biol. Chem. 276, 3394-3400). Here, we provide direct biochemical data using disulfide trapping to support a model that these peptides bind within a transmembrane helical triad formed by alpha-helices III, VI, and VII. We show that the three amino acids on the C terminus of the peptide analogs bind too weakly to exert a functional effect themselves. However, when a cysteine residue is placed on their N terminus they can be trapped by disulfide interchange to specific cysteines in helix III and VI and not to other cysteines, engineered into the C5aR. The trapped peptides function as agonists or partial antagonists, similar to the non-covalent parents from which they were derived. These data help to further refine the binding mode for C5a to the C5aR and suggest an approach and a binding site that may be applicable to studying other peptide binding receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550394     DOI: 10.1074/jbc.C400500200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Conformational changes in the parathyroid hormone receptor associated with activation by agonist.

Authors:  Beena E Thomas; Iwona Woznica; Dale F Mierke; Angela Wittelsberger; Michael Rosenblatt
Journal:  Mol Endocrinol       Date:  2008-02-07

2.  Covalent agonists for studying G protein-coupled receptor activation.

Authors:  Dietmar Weichert; Andrew C Kruse; Aashish Manglik; Christine Hiller; Cheng Zhang; Harald Hübner; Brian K Kobilka; Peter Gmeiner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-08       Impact factor: 11.205

3.  FP Tethering: a screening technique to rapidly identify compounds that disrupt protein-protein interactions.

Authors:  Jean M Lodge; T Justin Rettenmaier; James A Wells; William C Pomerantz; Anna K Mapp
Journal:  Medchemcomm       Date:  2014-03-01       Impact factor: 3.597

4.  Aptamers that bind to the human complement component receptor hC5aR1 interfere with hC5aR1 interaction to its hC5a ligand.

Authors:  Penmetcha K R Kumar
Journal:  Mol Biol Rep       Date:  2018-07-06       Impact factor: 2.316

5.  Turning a protein kinase on or off from a single allosteric site via disulfide trapping.

Authors:  Jack D Sadowsky; Mark A Burlingame; Dennis W Wolan; Christopher L McClendon; Matthew P Jacobson; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-23       Impact factor: 11.205

6.  Third extracellular loop (EC3)-N terminus interaction is important for seven-transmembrane domain receptor function: implications for an activation microswitch region.

Authors:  Soumendra Rana; Thomas J Baranski
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

7.  Mapping peptide hormone-receptor interactions using a disulfide-trapping approach.

Authors:  Paul Monaghan; Beena E Thomas; Iwona Woznica; Angela Wittelsberger; Dale F Mierke; Michael Rosenblatt
Journal:  Biochemistry       Date:  2008-05-07       Impact factor: 3.162

8.  Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping.

Authors:  Maoqing Dong; Xiequn Xu; Alicja M Ball; Joshua A Makhoul; Polo C-H Lam; Delia I Pinon; Andrew Orry; Patrick M Sexton; Ruben Abagyan; Laurence J Miller
Journal:  FASEB J       Date:  2012-09-10       Impact factor: 5.191

9.  Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptor.

Authors:  S Nijmeijer; H Engelhardt; S Schultes; A C van de Stolpe; V Lusink; C de Graaf; M Wijtmans; E E J Haaksma; I J P de Esch; K Stachurski; H F Vischer; R Leurs
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 10.  Function, structure and therapeutic potential of complement C5a receptors.

Authors:  P N Monk; A-M Scola; P Madala; D P Fairlie
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.